[1]
“THERAPEUTIC POTENTIAL OF GLP-1 RECEPTOR AGONISTS IN ALZHEIMER’S DISEASE: INSIGHTS FROM PRECLINICAL AND CLINICAL EVIDENCE”, IJITSS, vol. 4, no. 4(48), Dec. 2025, doi: 10.31435/ijitss.4(48).2025.4385.